CelluScience
Commercial- Indications
- Cellulite
Company intelligence / Profile preview
Medestea has commercialized several nutraceutical and cosmetic products internationally. Its flagship supplement CelluScience® demonstrated statistically significant reductions in thigh and abdominal circumference in a University of Siena clinical study. The company has also pursued patents on appetite control sprays and mood enhancers. There are references to early-stage R&D into monoclonal antibodies against HIV and cell therapies targeting AIDS/cancer but no evidence these have reached clinical trials.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medestea Biotech S.p.A..